How (and why) to build a freestanding emergency department

Freestanding emergency departments (FSEDs) roughly doubled in number in the U.S., to around 400, between 2009 and 2014.

There’s no reason to believe the pace has slowed, and a March 4 article in Healthcare Design magazine looks at the market factors fueling the business model’s (ahem) emergence before outlining considerations architects and builders should take into account before breaking ground.

Even if only because you didn’t see FSEDs coming, or at least not growing quite so fast, it’s an interesting read: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.